Welltower Inc. (NYSE:WELL - Get Free Report) reached a new 52-week high on Wednesday following a better than expected earnings announcement. The stock traded as high as $219.59 and last traded at $216.7820, with a volume of 98284 shares. The stock had previously closed at $214.23.
The real estate investment trust reported $1.02 earnings per share for the quarter, beating analysts' consensus estimates of $0.73 by $0.29. Welltower had a return on equity of 2.46% and a net margin of 8.64%.The firm had revenue of $3.35 billion for the quarter, compared to analysts' expectations of $3.09 billion. During the same quarter last year, the firm earned $1.20 earnings per share. The firm's revenue for the quarter was up 38.3% compared to the same quarter last year. Welltower has set its FY 2026 guidance at 6.210-6.350 EPS.
Welltower Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 21st. Shareholders of record on Wednesday, May 13th will be given a $0.74 dividend. The ex-dividend date of this dividend is Wednesday, May 13th. This represents a $2.96 annualized dividend and a yield of 1.4%. Welltower's dividend payout ratio (DPR) is 211.43%.
Key Stories Impacting Welltower
Here are the key news stories impacting Welltower this week:
- Positive Sentiment: Q1 results beat expectations — reported GAAP net income of $1.02/share, revenue $3.35B (vs. ~$3.09B est.), and normalized FFO of $1.47/share (up 23% YoY). Same-store NOI rose 16.4% driven by a 22.1% gain in the Seniors Housing Operating portfolio and occupancy/RevPOR improvement, supporting growth and cash generation. Welltower Reports First Quarter 2026 Results
- Positive Sentiment: Guidance and balance sheet strength — company provided FY2026 EPS guidance of $6.210–$6.350 and reported strong liquidity (~$11.1B available) with Net Debt / Adjusted EBITDA ~2.73x and recent debt reductions (including $700M of senior note repayment). These items support capital deployment and credit profile. Welltower trades higher after Q1 earnings beat estimates, 2026 guidance raised
- Positive Sentiment: FFO and other analyst checks confirm beat — independent commentary (Zacks) flagged FFO and revenue beats versus estimates, reinforcing the headline print and supporting valuation re-rating for growth in seniors housing. Welltower (WELL) Q1 FFO and Revenues Beat Estimates
- Neutral Sentiment: Quarterly dividend declared — $0.74 per share payable May 21 to holders of record May 13 (ex-dividend May 13). Yield ~1.4%; supportive of income profile but low yield limits near-term price impact.
- Neutral Sentiment: Supplementary materials and business update available — company issued a business update and slide deck with transaction and portfolio detail for investors; useful for due diligence but not a standalone catalyst. View Press Release / Slide Deck
- Negative Sentiment: Filed resale prospectus supplement to register additional shares — management says this is to enhance capital flexibility, but it creates potential dilution over time and could cap near-term upside if used to raise equity. Monitor how many shares are ultimately issued and the intended use of proceeds. Welltower Registers Additional Shares to Enhance Capital Flexibility
Analyst Upgrades and Downgrades
Several research firms have commented on WELL. Royal Bank Of Canada raised their price objective on Welltower from $207.00 to $230.00 and gave the company an "outperform" rating in a research report on Tuesday, February 24th. Scotiabank raised their price objective on Welltower from $214.00 to $236.00 and gave the company a "sector outperform" rating in a research report on Monday, March 2nd. Morgan Stanley boosted their price target on Welltower from $200.00 to $215.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 18th. Wall Street Zen cut Welltower from a "hold" rating to a "sell" rating in a research note on Saturday, February 14th. Finally, Citigroup boosted their price target on Welltower from $215.00 to $245.00 and gave the stock a "buy" rating in a research note on Wednesday, February 18th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Welltower has a consensus rating of "Moderate Buy" and an average price target of $225.43.
Read Our Latest Research Report on Welltower
Institutional Trading of Welltower
Several hedge funds and other institutional investors have recently bought and sold shares of the company. National Pension Service boosted its position in shares of Welltower by 2.1% during the third quarter. National Pension Service now owns 1,691,931 shares of the real estate investment trust's stock worth $301,401,000 after buying an additional 34,532 shares during the period. B&I Capital AG boosted its position in shares of Welltower by 5.7% during the third quarter. B&I Capital AG now owns 161,440 shares of the real estate investment trust's stock worth $28,759,000 after buying an additional 8,650 shares during the period. GDS Wealth Management boosted its position in shares of Welltower by 13.7% during the third quarter. GDS Wealth Management now owns 63,763 shares of the real estate investment trust's stock worth $11,359,000 after buying an additional 7,699 shares during the period. New York Life Investment Management LLC boosted its position in shares of Welltower by 4.3% during the third quarter. New York Life Investment Management LLC now owns 97,366 shares of the real estate investment trust's stock worth $17,345,000 after buying an additional 4,019 shares during the period. Finally, Benchmark Investment Advisors LLC acquired a new position in shares of Welltower during the third quarter worth approximately $901,000. 94.80% of the stock is owned by institutional investors.
Welltower Trading Up 0.5%
The business's 50 day moving average price is $205.57 and its two-hundred day moving average price is $195.41. The company has a market capitalization of $151.69 billion, a price-to-earnings ratio of 154.01, a price-to-earnings-growth ratio of 1.10 and a beta of 0.83. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.46 and a current ratio of 3.46.
Welltower Company Profile
(
Get Free Report)
Welltower Inc NYSE: WELL is a real estate investment trust (REIT) that acquires and manages real estate serving the health care industry. The company specializes in healthcare infrastructure, owning and operating a diversified portfolio of senior housing, post-acute and long-term care communities, and outpatient medical properties. Welltower's assets are designed to support the delivery of health care services through a combination of leased properties, joint ventures, and other capital arrangements with health care operators and providers.
The company's property types include assisted living, memory care, independent living and skilled nursing facilities, as well as medical office buildings and other outpatient-care real estate such as ambulatory surgery centers and specialty clinics.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Welltower, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Welltower wasn't on the list.
While Welltower currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.